Related Experiment Video
Updated: Jun 29, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Self-assembled metal-phenolic nanocomplexes comprised of green tea catechin for tumor-specific ferroptosis
Min Wang1, Aoling Yu1, Wen Han1
1MOE Key Laboratory for Analytical Science of Food Safety and Biology, Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety, College of Chemistry, Fuzhou University, Fuzhou, Fujian, 350116, China.
Abstract:
Ferroptosis, a newly discovered form of regulated cell death, has garnered significant attention in the field of tumor therapy. However, the presence of overexpressed glutathione (GSH) and insufficient levels of H2O2 in the tumor microenvironment (TME) hinders the occurrence of ferroptosis. In response to these challenges, here we have constructed the self-assembled nanocomplexes (FeE NPs) utilizing epigallocatechin-3-gallate (EGCG) from green tea polyphenols and metal ions (Fe3+) as components. After grafting PEG, the nanocomplexes (FeE@PEG NPs) exhibit good biocompatibility and synergistically enhanced tumor-inhibitory properties. FeE@PEG NPs can be disassembled by H2O2 in the TME, leading to the rapid release of Fe3+ and EGCG. The released Fe3+ produces large amounts of toxic •OH by the Fenton reactions while having minimal impact on normal cells. The generated •OH effectively induces lipid peroxidation, which leads to ferroptosis in tumor cells. Meanwhile, the released EGCG can autoxidize to produce H2O2, which further promotes the production of •OH radicals and increases lipid peroxide levels. Moreover, EGCG also depletes the high levels of intracellular GSH, leading to an intracellular redox imbalance and triggering ferroptosis. This study provides new insights into advancing anticancer ferroptosis through rational material design, offering promising avenues for future research.
Insights
This study introduces novel nanocomplexes (FeE@PEG NPs) that induce ferroptosis, a cell death pathway, in tumor cells. These nanoparticles overcome tumor microenvironment challenges to enhance cancer therapy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Ferroptosis, a regulated cell death, is a promising cancer therapy target.
- Tumor microenvironments often inhibit ferroptosis due to high glutathione (GSH) and low hydrogen peroxide (H2O2).
Purpose of the Study:
- To develop a novel nanocomplex for targeted ferroptosis induction in tumors.
- To overcome the challenges posed by the tumor microenvironment for effective cancer treatment.
Main Methods:
- Self-assembled nanocomplexes (FeE NPs) were constructed using epigallocatechin-3-gallate (EGCG) and Fe3+ ions.
- PEGylation yielded FeE@PEG NPs with enhanced biocompatibility and tumor-inhibitory properties.
- FeE@PEG NPs were designed to disassemble in the tumor microenvironment, releasing Fe3+ and EGCG.
Main Results:
- Released Fe3+ generates hydroxyl radicals (•OH) via Fenton reactions, inducing lipid peroxidation and ferroptosis.
- Released EGCG produces H2O2, further promoting •OH generation and lipid peroxidation.
- EGCG depletes intracellular GSH, causing redox imbalance and triggering ferroptosis in tumor cells.
Conclusions:
- FeE@PEG NPs effectively induce ferroptosis in tumor cells by addressing TME-related limitations.
- This rational material design offers a promising strategy for advancing anticancer ferroptosis therapy.

